Table of Content

Table of Contents

Global Pre-filled Hemostasis Agents Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pre-filled Hemostasis Agents Market by Value
2.2.1 Global Pre-filled Hemostasis Agents Revenue by Type
2.2.2 Global Pre-filled Hemostasis Agents Market by Value (%)
2.3 Global Pre-filled Hemostasis Agents Market by Production
2.3.1 Global Pre-filled Hemostasis Agents Production by Type
2.3.2 Global Pre-filled Hemostasis Agents Market by Production (%)

3. The Major Driver of Pre-filled Hemostasis Agents Industry
3.1 Historical & Forecast Global Pre-filled Hemostasis Agents Demand
3.2 Largest Application for Pre-filled Hemostasis Agents (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Pre-filled Hemostasis Agents Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Pre-filled Hemostasis Agents Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Pre-filled Hemostasis Agents Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Pre-filled Hemostasis Agents Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Pre-filled Hemostasis Agents Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Pre-filled Hemostasis Agents Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Pre-filled Hemostasis Agents Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Pre-filled Hemostasis Agents Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Pre-filled Hemostasis Agents Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Pre-filled Hemostasis Agents Average Price Trend
12.1 Market Price for Each Type of Pre-filled Hemostasis Agents in US (2018-2022)
12.2 Market Price for Each Type of Pre-filled Hemostasis Agents in Europe (2018-2022)
12.3 Market Price for Each Type of Pre-filled Hemostasis Agents in China (2018-2022)
12.4 Market Price for Each Type of Pre-filled Hemostasis Agents in Japan (2018-2022)
12.5 Market Price for Each Type of Pre-filled Hemostasis Agents in India (2018-2022)
12.6 Market Price for Each Type of Pre-filled Hemostasis Agents in Korea (2018-2022)
12.7 Market Price for Each Type of Pre-filled Hemostasis Agents in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Pre-filled Hemostasis Agents Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Pre-filled Hemostasis Agents

14. Pre-filled Hemostasis Agents Competitive Landscape
14.1 Merck
14.1.1 Merck Company Profiles
14.1.2 Merck Product Introduction
14.1.3 Merck Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Thermo Fisher Scientific
14.2.1 Thermo Fisher Scientific Company Profiles
14.2.2 Thermo Fisher Scientific Product Introduction
14.2.3 Thermo Fisher Scientific Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 CarboMer, Inc.
14.3.1 CarboMer, Inc. Company Profiles
14.3.2 CarboMer, Inc. Product Introduction
14.3.3 CarboMer, Inc. Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Advance Medical Solutions Group
14.4.1 Advance Medical Solutions Group Company Profiles
14.4.2 Advance Medical Solutions Group Product Introduction
14.4.3 Advance Medical Solutions Group Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Baxter International Inc.
14.5.1 Baxter International Inc. Company Profiles
14.5.2 Baxter International Inc. Product Introduction
14.5.3 Baxter International Inc. Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Vascular Solutions, Inc.
14.6.1 Vascular Solutions, Inc. Company Profiles
14.6.2 Vascular Solutions, Inc. Product Introduction
14.6.3 Vascular Solutions, Inc. Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 CryoLife, Inc.
14.7.1 CryoLife, Inc. Company Profiles
14.7.2 CryoLife, Inc. Product Introduction
14.7.3 CryoLife, Inc. Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Teleflex
14.8.1 Teleflex Company Profiles
14.8.2 Teleflex Product Introduction
14.8.3 Teleflex Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Gelita GmbH
14.9.1 Gelita GmbH Company Profiles
14.9.2 Gelita GmbH Product Introduction
14.9.3 Gelita GmbH Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Johnson & Johnson
14.10.1 Johnson & Johnson Company Profiles
14.10.2 Johnson & Johnson Product Introduction
14.10.3 Johnson & Johnson Pre-filled Hemostasis Agents Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 AK Scientific, Inc.
14.12 Crescent Chemical Co., Inc.
14.13 Penta Manufacturing Company
14.14 Fisher Scientific
14.15 MP Biomedicals
14.16 Vickers Laboratories Limited
14.17 Avantor
14.18 Apollo Scientific Ltd
14.19 Nacalai Tesque Inc.
14.20 Kanto Kagaku
14.21 Nippi. Inc.
14.22 Shanghai Acmec Biochemical Co., Ltd
14.23 Beijing Jinming Biotechnology Co., Ltd
14.24 Hunan Baihui Biotechnology Co., Ltd
14.25 Shanghai Jiade'er Chemical Technology Co., Ltd
14.26 Beijing Wokai Biotechnology Co., Ltd
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Pre-filled Hemostasis Agents Industry (Volume)
Figure 2. Pre-filled Hemostasis Agents Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Pre-filled Hemostasis Agents Revenue in 2022
Figure 5. US Pre-filled Hemostasis Agents Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Pre-filled Hemostasis Agents Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Pre-filled Hemostasis Agents Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Pre-filled Hemostasis Agents Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Pre-filled Hemostasis Agents Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Pre-filled Hemostasis Agents Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Pre-filled Hemostasis Agents Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Pre-filled Hemostasis Agents Revenue, by Type (Million USD) (2018-2028)
Table 4. Pre-filled Hemostasis Agents Production, by Type (K Unit) (2018-2028)
Table 5. Pre-filled Hemostasis Agents Demand (K Unit) by Application (2018-2028)
Table 6. Pre-filled Hemostasis Agents Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Pre-filled Hemostasis Agents Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Pre-filled Hemostasis Agents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Pre-filled Hemostasis Agents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Pre-filled Hemostasis Agents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Pre-filled Hemostasis Agents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Pre-filled Hemostasis Agents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Pre-filled Hemostasis Agents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Pre-filled Hemostasis Agents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Pre-filled Hemostasis Agents in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Pre-filled Hemostasis Agents in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Pre-filled Hemostasis Agents in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Pre-filled Hemostasis Agents in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Pre-filled Hemostasis Agents in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Pre-filled Hemostasis Agents in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Pre-filled Hemostasis Agents in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Merck Profiles
Table 61. Merck Pre-filled Hemostasis Agents Product Introduction
Table 62. Merck Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Merck Strategic initiatives
Table 64. Thermo Fisher Scientific Profiles
Table 65. Thermo Fisher Scientific Pre-filled Hemostasis Agents Product Introduction
Table 66. Thermo Fisher Scientific Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Thermo Fisher Scientific Strategic initiatives
Table 68. CarboMer, Inc. Profiles
Table 69. CarboMer, Inc. Pre-filled Hemostasis Agents Product Introduction
Table 70. CarboMer, Inc. Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. CarboMer, Inc. Strategic initiatives
Table 72. Advance Medical Solutions Group Profiles
Table 73. Advance Medical Solutions Group Pre-filled Hemostasis Agents Product Introduction
Table 74. Advance Medical Solutions Group Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Advance Medical Solutions Group Strategic initiatives
Table 76. Baxter International Inc. Profiles
Table 77. Baxter International Inc. Pre-filled Hemostasis Agents Product Introduction
Table 78. Baxter International Inc. Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Baxter International Inc. Strategic initiatives
Table 80. Vascular Solutions, Inc. Profiles
Table 81. Vascular Solutions, Inc. Pre-filled Hemostasis Agents Product Introduction
Table 82. Vascular Solutions, Inc. Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Vascular Solutions, Inc. Strategic initiatives
Table 84. CryoLife, Inc. Profiles
Table 85. CryoLife, Inc. Pre-filled Hemostasis Agents Product Introduction
Table 86. CryoLife, Inc. Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. CryoLife, Inc. Strategic initiatives
Table 88. Teleflex Profiles
Table 89. Teleflex Pre-filled Hemostasis Agents Product Introduction
Table 90. Teleflex Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Teleflex Strategic initiatives
Table 92. Gelita GmbH Profiles
Table 93. Gelita GmbH Pre-filled Hemostasis Agents Product Introduction
Table 94. Gelita GmbH Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Gelita GmbH Strategic initiatives
Table 97. Johnson & Johnson Profiles
Table 98. Johnson & Johnson Pre-filled Hemostasis Agents Product Introduction
Table 99. Johnson & Johnson Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Johnson & Johnson Strategic initiatives
Table 101. AK Scientific, Inc. Profiles
Table 102. AK Scientific, Inc. Pre-filled Hemostasis Agents Product Introduction
Table 103. AK Scientific, Inc. Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. AK Scientific, Inc. Strategic initiatives
Table 105. Crescent Chemical Co., Inc. Profiles
Table 106. Crescent Chemical Co., Inc. Pre-filled Hemostasis Agents Product Introduction
Table 107. Crescent Chemical Co., Inc. Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Crescent Chemical Co., Inc. Strategic initiatives
Table 109. Penta Manufacturing Company Profiles
Table 110. Penta Manufacturing Company Pre-filled Hemostasis Agents Product Introduction
Table 111. Penta Manufacturing Company Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Penta Manufacturing Company Strategic initiatives
Table 113. Fisher Scientific Profiles
Table 114. Fisher Scientific Pre-filled Hemostasis Agents Product Introduction
Table 115. Fisher Scientific Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Fisher Scientific Strategic initiatives
Table 117. MP Biomedicals Profiles
Table 118. MP Biomedicals Pre-filled Hemostasis Agents Product Introduction
Table 119. MP Biomedicals Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. MP Biomedicals Strategic initiatives
Table 121. Vickers Laboratories Limited Profiles
Table 122. Vickers Laboratories Limited Pre-filled Hemostasis Agents Product Introduction
Table 123. Vickers Laboratories Limited Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. Vickers Laboratories Limited Strategic initiatives
Table 125. Avantor Profiles
Table 126. Avantor Pre-filled Hemostasis Agents Product Introduction
Table 127. Avantor Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 128. Avantor Strategic initiatives
Table 129. Apollo Scientific Ltd Profiles
Table 130. Apollo Scientific Ltd Pre-filled Hemostasis Agents Product Introduction
Table 131. Apollo Scientific Ltd Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 132. Apollo Scientific Ltd Strategic initiatives
Table 133. Nacalai Tesque Inc. Profiles
Table 134. Nacalai Tesque Inc. Pre-filled Hemostasis Agents Product Introduction
Table 135. Nacalai Tesque Inc. Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 136. Nacalai Tesque Inc. Strategic initiatives
Table 137. Kanto Kagaku Profiles
Table 138. Kanto Kagaku Pre-filled Hemostasis Agents Product Introduction
Table 139. Kanto Kagaku Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 140. Kanto Kagaku Strategic initiatives
Table 141. Nippi. Inc. Profiles
Table 142. Nippi. Inc. Pre-filled Hemostasis Agents Product Introduction
Table 143. Nippi. Inc. Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 144. Nippi. Inc. Strategic initiatives
Table 145. Shanghai Acmec Biochemical Co., Ltd Profiles
Table 146. Shanghai Acmec Biochemical Co., Ltd Pre-filled Hemostasis Agents Product Introduction
Table 147. Shanghai Acmec Biochemical Co., Ltd Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 148. Shanghai Acmec Biochemical Co., Ltd Strategic initiatives
Table 149. Beijing Jinming Biotechnology Co., Ltd Profiles
Table 150. Beijing Jinming Biotechnology Co., Ltd Pre-filled Hemostasis Agents Product Introduction
Table 151. Beijing Jinming Biotechnology Co., Ltd Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 152. Beijing Jinming Biotechnology Co., Ltd Strategic initiatives
Table 153. Hunan Baihui Biotechnology Co., Ltd Profiles
Table 154. Hunan Baihui Biotechnology Co., Ltd Pre-filled Hemostasis Agents Product Introduction
Table 155. Hunan Baihui Biotechnology Co., Ltd Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 156. Hunan Baihui Biotechnology Co., Ltd Strategic initiatives
Table 157. Shanghai Jiade'er Chemical Technology Co., Ltd Profiles
Table 158. Shanghai Jiade'er Chemical Technology Co., Ltd Pre-filled Hemostasis Agents Product Introduction
Table 159. Shanghai Jiade'er Chemical Technology Co., Ltd Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 160. Shanghai Jiade'er Chemical Technology Co., Ltd Strategic initiatives
Table 161. Beijing Wokai Biotechnology Co., Ltd Profiles
Table 162. Beijing Wokai Biotechnology Co., Ltd Pre-filled Hemostasis Agents Product Introduction
Table 163. Beijing Wokai Biotechnology Co., Ltd Pre-filled Hemostasis Agents Production (Unit), Revenue (Million USD) (2018-2022)
Table 164. Beijing Wokai Biotechnology Co., Ltd Strategic initiatives